Fortrea Holdings Inc. FTRE Clinical Services Segment — Segment Operating Income

Similar metrics at other companies

CRLSegment operating income — Operating Income (Loss)

$200.49M+55.5%

WUConsumer Services — Operating Income

$16.2M-40.2%

AMTServices — Operating Income (Loss)

$23.8M-28.5%

BCCorporate Segment — Operating Income (Loss)

-$41.3M-22.2%

AITService Center Segment — Operating Income

$98.37M-0.9%

DELLClient Solutions — Operating Income (Loss)

$1.17B+79.2%

Questions, answered.

What is Fortrea Holdings Inc.'s clinical services segment — segment operating income?

Fortrea Holdings Inc. (FTRE) reported clinical services segment — segment operating income of $21.85M in Q4 2025.

How has Fortrea Holdings Inc.'s clinical services segment — segment operating income changed year-over-year?

Fortrea Holdings Inc.'s clinical services segment — segment operating income decreased by 8.0% year-over-year, from $23.75M to $21.85M.

What is the long-term trend for Fortrea Holdings Inc.'s clinical services segment — segment operating income?

Over 2 years (2023 to 2025), Fortrea Holdings Inc.'s clinical services segment — segment operating income has grown at a -28.3% compound annual growth rate (CAGR), from $169.8M to $87.4M.

What does clinical services segment — segment operating income mean?

This metric represents the operating profit or loss generated specifically by the clinical services segment, calculated by subtracting direct costs and operating expenses from segment revenues. It serves as a key performance indicator for the efficiency and operational success of the company's clinical trial management services. Investors use this to evaluate the core business profitability excluding corporate-level overheads and financing costs.